Ionis Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 94 U.S.-traded ETFs. IONS has around 9.9M shares in the U.S. ETF market. The largest ETF holder of IONS is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.43M shares. Investors may also find of interest that the ETF with the largest allocation to IONS stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 3.26%. On average, U.S. ETFs allocate 0.33% of IONS to their portfolios.
Additionally, IONS is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IONS as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 68.27%.